BROLUCIZUMAB (Beovu®)

Clinical Indication

Diabetic Macular oedema

Comments

In line with NICE TA820

Date of classification

September 2022

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.